Non-Small Cell Lung Cancer Clinical Trial Pipeline Boom As Over 100 Companies Leading The Charge In Research And ...
(MENAFN- PR Newswire) Advancements in targeted therapies have transformed the treatment landscape for NSCLC, enabling precision medicine approaches that improve outcomes. These therapies focus on specific genetic mutations or molecular drivers, such as …